Perrigo Company plc is a prominent global healthcare supplier that specializes in the development, manufacture, and distribution of over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients. As the largest manufacturer of OTC pharmaceutical products for the store brand market, Perrigo has established itself as a leader in consumer health. The company has shifted its focus to consumer self-care since divesting its animal health and generic pharmaceuticals businesses in 2018. A significant portion of its sales is generated in North America, where it provides private-label consumer health goods to major retailers such as Walmart, Amazon, Costco, and CVS. Additionally, Perrigo operates in Europe, Australia, and parts of Asia, marketing national brands like Compeed, Solpadeine, Coldrex, and ellaOne. With a diverse product portfolio and a commitment to innovation, Perrigo serves customers worldwide.
HRA Pharma, SA is a pharmaceutical company based in Paris, France, specializing in the development and commercialization of products targeted at women's health and endocrine disorders. Founded in 1996, the company offers a range of reproductive health products such as Norlevo for emergency contraception, Cicatridine for vaginitis, and various hormone replacement therapies. In the endocrine sector, it provides treatments like Lysodren for adrenal cancer and Bemedrex for asthma. HRA Pharma's development pipeline includes promising candidates such as ella/ellaOne, an emergency contraceptive pill, and treatments for uterine fibroids and rare endocrine disorders like Cushing's syndrome. The company markets its products directly in the European Union, including key markets like France, Germany, and the United Kingdom, while also utilizing license agreements for distribution internationally. HRA Pharma operates additional locations in Bochum, London, and New York.
Ranir
Acquisition in 2019
Ranir is a prominent manufacturer of oral and personal healthcare products based in Grand Rapids, Michigan. The company specializes in producing a variety of consumer-oriented items, including tooth-whitening strips and gels, toothbrushes, dental floss, and travel kits. By offering store brand and contract manufacturing services, Ranir collaborates closely with major retailers and branded oral care companies globally. Their dedicated research, development, and manufacturing teams work in partnership with clients from the initial concept to final product delivery, fostering strong, long-term relationships. This collaborative approach enables Ranir to deliver quality products that help their partners succeed in the competitive market.
Laboratoire de la Mer
Acquisition in 2016
Laboratoire de la Mer SAS, based in Saint-Malo, France, specializes in the development and marketing of health and personal care products. The company offers a diverse range of items, including nasal congestion relief products, ear cleansing washes for managing excess ear wax, and oral and dental care solutions aimed at older adults with sore or receding gums. Additionally, Laboratoire de la Mer produces dietary supplements and cosmetic products, all of which are grounded in research focused on marine resources and seaweed. The efficacy and tolerance of these products have been validated through clinical studies, ensuring their reliability for consumers.
Geiss, Destin & Dunn
Acquisition in 2016
Geiss, Destin & Dunn is a small national distributor specializing in over-the-counter healthcare and consumer goods. The company provides a range of products, including healthcare, personal care, diabetic care, and pet health items. Its distribution network serves wholesalers, retailers, and institutions throughout the United States, ensuring a broad reach in the healthcare and consumer goods markets.
ScarAway
Acquisition in 2015
ScarAway's proven Advanced Silicone Technology has been shown in countless clinical studies to reduce the appearance of scars, new and old. This innovative technology simulates the natural barrier function of healthy skin, hydrating scar tissue to soften the scar, shrinking, flattening and fading it. Used after surgery or injury, our advanced technology helps treat and prevent abnormal scar formation. ScarAway helps alleviate the itching and discomfort associated with scars.
Omega Pharma
Acquisition in 2014
Omega Pharma engages in the development and sale of prescription-free health and personal care products to pharmacies and other medical sectors together with its subsidiaries. It offers personal care products for face and body, sun care products, and baby-specific products under the Bodysol/Galenco, ACO, Lactacyd, Claire Fisher, Bergasol, and Biodermal brand names; and medicated skin care products for various skin conditions and allergies under the Dermalex, Septivon, and Wartner brands. Omega Pharma also provides cough and cold products, and allergy products, as well as aromatherapy and homeopathic solutions under the Bittner/Aflubin, Prevalin/Beconase, Physiomer/Libenar, and Phytosun brand names; and anti-parasites under the Paranix and Jungle Formula brands for human, as well as Paravet/Clément-Thékan brand name for pets. In addition, it offers vitamins, minerals, supplements, and natural remedies under the Davitamon, Biover, Abtei, Granufunk and Bional brand names; weight management products under the XLS and XLS Medical brands; pregnancy tests and self-diagnostic products under the Predictor brand name; pain relief products under the Solpadeine and Optalidon brands; eye care products under the Opticalm(ax) brand; and sleep aid products under the brand names of Silence and Nytol. Omega Pharma primarily operates in Europe, Turkey, Australia, Argentina, and South-Africa. Marc Coucke and Yvan Vindevogel founded it in 1987. Omega Pharma has its headquarters in Nazareth in Belgium. It operates as a subsidiary of Perrigo Company.
Elan Corporation
Acquisition in 2013
Elan Corporation, plc is a biotechnology company based in Ireland, focused on addressing significant unmet medical needs through innovative scientific solutions. Established in 1969, Elan operates two main business units: BioNeurology and Elan Drug Technologies. This structure allows the company to develop and manufacture pharmaceuticals targeting neurodegenerative diseases, such as Alzheimer's and Parkinson's, as well as autoimmune disorders, including multiple sclerosis and Crohn's disease. Elan's commitment is to improve the lives of patients and their families by advancing medical treatments and therapies in these critical areas.
Elan Pharmaceuticals
Acquisition in 2013
Elan Pharmaceuticals, Inc. is an Ireland-based neuroscience-based technology company that engages in the research and development, and the sale of pharmaceutical products. The company was founded in 1986 and is based in South San Francisco, California. The company discovers, develops, manufactures and markets therapies for neurodegenerative diseases, autoimmune diseases, and severe pain. All the drugs, manufactured by the company are delivered to broad range of pharmaceutical companies, ranging from large global organizations to development stage companies. The company through its drug technologies has developed improved formulations of 35 products that were launched in over 100 countries. The company also markets its product, TYSABRI in United States, the European Union, Switzerland, Canada, and Australia. The company has its R&D, marketing and manufacturing located in Ireland and the U.S. Elan is headquartered in Dublin, Ireland. Elan Pharmaceuticals, Inc was acquired by Perrigo Co. (PRGO), a U.S. maker of over-the-counter medicines, in 2013 for $8.6 billion, gaining a low-tax base for international expansion.
Fera Pharmaceuticals
Acquisition in 2013
Fera Pharmaceuticals is a Biotechnology company.
Rosemont Pharmaceuticals
Acquisition in 2013
Rosemont Pharmaceuticals Limited is a manufacturer and supplier of liquid medicines, specializing in oral liquid formulations designed for patients with swallowing difficulties. Founded in 1967 and based in Leeds, United Kingdom, the company’s extensive product range encompasses various therapeutic areas, including anesthesia, cardiovascular health, central nervous system disorders, endocrine system issues, gastrointestinal conditions, infections, malignant diseases, immunosuppression, musculoskeletal and joint diseases, as well as obstetrics, gynecology, and urinary-tract disorders. Rosemont Pharmaceuticals serves healthcare professionals and patients globally, providing accessible and effective liquid medication options to enhance patient health and well-being. Originally established as R.P. Drugs Limited, the company adopted its current name in 1994 and operates independently, having previously been a subsidiary of Acacia Biopharma Limited.
Velcera
Acquisition in 2013
Velcera is a specialty pharmaceutical company with a passion for assuring pets receive the medicines they need to support excellent overall health. At Velcera, they are dedicated to developing innovative, high-quality products for the pet health market. They comply with the highest standards of practice through all phases, from development to manufacturing to marketing.
CanAm Care
Acquisition in 2012
CanAm Care is a healthcare company that manufactures and retails medical equipments and devices.
Paddock Laboratories
Acquisition in 2011
Paddock Laboratories provides pharmaceutical manufacturer of generic Rx pharmaceuticals and OTC specialty products.
PBM Products
Acquisition in 2010
PBM Products is a company focused on the manufacturing, distribution, and marketing of consumer food, nutritional, and pharmaceutical products. Specializing in infant nutrition, PBM Products offers a diverse range of over 100 products designed to support the dietary needs of infants. These products are available in various retail stores globally, ensuring that consumers have access to essential nutritious options for their children. The company's commitment to quality and innovation positions it as a key player in the infant products market.
ORION Laboratories
Acquisition in 2010
ORION Laboratories manufactures and markets therapeutic pharmaceuticals. It specializes in cream and liquid fills.
Laboratorios Diba
Acquisition in 2008
Laboratorios Diba is a manufacturer specializing in both over-the-counter (OTC) and prescription pharmaceuticals. The company focuses on the design and production of a variety of medications, including antibiotics, hormonal treatments, and ophthalmic drugs. Through its commitment to quality and innovation, Laboratorios Diba aims to meet the diverse healthcare needs of patients and healthcare providers.
JB Laboratories
Acquisition in 2008
JB Laboratories is a contract manufacturer of OTC and nutrition products for leading healthcare suppliers in the U.S.
Brunel Healthcare Manufacturing Limited
Acquisition in 2008
Brunel Healthcare are the UK's leading manufacturer of vitamins, minerals and nutritional supplements. We specialise in private label and contract manufacture of shelf ready goods for the global marketplace. Our long standing base of private label customers includes some of the world's largest retailers, from whom we have won many awards. We also manufacture and pack many internationally recognised brands. We were proud recipients of the Queen’s Award for Enterprise in 2015. This is one of the most prestigious accolades that a British business can receive. We operate from a modern, purpose built 30,000m2 development and production facility in Derbyshire, Central England. Sector leading quality standards have been paramount to driving our continued growth. Licensed by the MHRA, we operate to cGMP standards.
Galpharm International
Acquisition in 2008
Galpharm International specializes in the manufacture and distribution of healthcare remedies in the United Kingdom. The company supplies a variety of non-prescription medicines, including allergy tablets, cough syrups, and nicotine replacement products. By offering a broad range of quality healthcare solutions, Galpharm aims to address various health needs in the market.
Agis Industries
Acquisition in 2005
Agis Industries is a developer and manufacturer of specialized generic pharmaceuticals and active pharmaceutical ingredients.
Wrafton Laboratories
Acquisition in 2001
Wrafton Laboratories is a supplier of store brand products to major grocery and pharmacy retailers in the U.K. and is a contract manufacturer of over-the-counter (OTC) pharmaceuticals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.